Dr Perla Eleftheriou : Haematology

Home
Dr Perla Eleftheriou

Bupa Platinum consultant
Fee assured
Verified account
Open Referral network

Overview

Specialises in

General

Offers

Face-to-face consultations
Video and telephone consultations

About me

Consultant Haematologist at University College Hospital in London and Honorary Senior Clinical Lecturer at UCL

Area of special interest : Red Cell Disorders, which include haemoglobinopathies and rare anaemias polycythaemias, iron deficiency and iron overload disorders.

Graduated from the University of Giessen in Germany in 2000 . Awarded the MRCP by the Royal College of Physicians in 2008 and the FRCPath from the Royal College of Pathologists in 2013.
Completed haematology training as a specialist Registrar at Bartshealth NHS trust and gained a lot of experience in the broad spectrum of malignant and non-malignant haematology, including laboratory diagnostics. I worked at UCLH/UCL for 2 and a half years (2004-2007) , studying the effect and tolerability of different iron chelators in adult and paediatric patients with haemoglobinopathies and other rare transfusion dependent anaemias and transfusional iron overload

Serves as scientific adviser for Thalassaemia International Federation.
Undergraduate and postgraduate teaching responsibilities.
Principal and Co-investigator in numerous clinical trials in the field of sickle cell disease, thalassaemia and other rare anaemias.

Areas of interest

My area of special interest is Red Cell Disorders, which include haemoglobinopathies ( thalassaemia, sickle cell disease) and rare anaemias but also polycythaemias and iron overload disorders. I treat patients with iron deficiencies or general haematology problems ( i.e., abnormal blood counts, )

Medical secretaries

Yasmin Mohammed
HCA UK at University College Hospital 5th Floor Macmillan Cancer Centre Huntley Street London WC1E 6AG
07451 01110
07545 101110
Yasmin.mohammed@nhs.net

About me

Current NHS consultant posts held

Consultant haematologist at UCLH

Research interests

special research interest in different iron chelators and their effect on the myocardial iron removal. Presented data as posters and oral presentations at various international conferences.
Extensive experience in clinical trials.Currently responsible for Red cell clinical trial clinics at UCLH, investigating new anti-sickling agents, iron chelators, agents which increase the haemoglobin in thalassaemia.
I serve as scientific adviser of thalassaemia integration federation.

Personal interests

I have extensive experience in formal and informal teaching.
Teaching regularly at UCL and Medical School of Nicosia, Cyprus.
Leading a thalasaemia fellowship program at UCLH.
Tutor and program coordinator of upcoming haemogobinopathy MSc course.
In my spare time i enjoy my family, travelling, theatre and playing the piano.

Awards received

1) A.G Leventis Foundation Scholarship for young scientists for 3 consecutive years.
2)In 2006 scholarship for young researchers in Haemoglobinopathies by the European School of Genetics.

(Additional) Languages spoken

Publications

1)J Overton, P Eleftheriou, W Sapsford
Recurrent acute lower-limb ischaemia with multiple organ infarctions secondary to acute
myeloid leukaemia.
Ann Vasc Surg 2012 Nov 28;26(8)
2)M Garbowski, P Eleftheriou, D Pennell, M Tanner, J Porter
Impact of compliance, Ferritin and LIC on long-term trends in myocardial T2* with
Deferasirox.
In ASH Annual Meeting. Volume 112. San Francisco: Blood; 2008::49-50.
3)J Glanville, P Eleftheriou, J Porter
MRI evidence of cardiac iron accumulation in myelodyspasia and unusual anaemias
Blood. 2006;108 abstract 1553.
4)J Porter, M Tanner,D Pennel , P Eleftheriou
Improved myocardial T2* in transfusion dependent anaemias receiving ICL 670
Blood 2005-ASH conference; Abstract 160
5)Eleftheriou P, Tanner M, Pennel D, Porter J
Myocardial T2* improves significantly with one year of treatment with Deferasirox in
transfusion dependent anaemias.
Abstract 66/10th international Conference on Thalassaemia& Haemoglobinopathies in Dubai
6)Eleftheriou P, Tanner M, Pennel D, Porter J
Response of myocardial T2* to oral Deferasirox for 1 year in 29 patients with transfusion-
dependent anaemias; a subgroup analysis.
Haematologica. 2006;91(s1):366â€“366.
7)Eleftheriou P, Leddham D, Eccersley L, Shah F, Davis B, Hall-Craggs M,Porter J Heterogeneity of genetic causation, presentation and treatment response of
extramedullary haematopoietic causes in thalassaemia syndromes
10th international Conference on Thalassaemia & haemoglobinopathies (Dubai),Abs.100
8)Combination of automated red cell exchanges and hydroxycarbamidein sickle cell disease
P Eleftheriou et al
Poster at 9th Sickle cell and thalassaemia conference, London October 2015

My qualifications & training

My private practice

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

X3570
Therapeutic venesection - (1-5)
20365
Follow-up out-patient consultation - remote - (1-5)
X3590
Intravenous infusion (as sole procedure) - (1-5)

Report this page Print page

Finder

Note: